Approval · Notice of Compliance 20295 · 2018
EZETIMIBE: Notice of Compliance 20295
Issued January 10, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20295
- Date
- January 10, 2018
- Company
- Pro Doc LimiteeLaval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Licensing agreement between two companies
- Canadian reference product
- EZETROL
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| EZETIMIBE | 02422549 | Marketed |
Medicinal ingredients
- EZETIMIBE 10 MG per TAB